Plus: Mirxes raises $50M series D, files for IPO in Hong Kong and updates from Kriya, Kincell, Tarsus, Infinity-MEI

a16z, Deerfield co-lead $65M series A for UC Berkeley spinout’s small molecule deubiquitination platform

Nextech Invest leads $85M series A to make the difficult-to-drug protein class amenable to small molecules

U.K. biotech sells one ion channel program, keeps another

Why Abeona thinks its gene therapy platform will work for cystic fibrosis where others fell short

How closed-loop chemogenetics could help inhibit seizure-generating neurons